Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - OTHER CURRENT ASSETS
Other Current Assets KALV - KalVista Pharmaceuticals, Inc.
4.42 M
LAST VALUE
-35.56%
2 YEAR CAGR
5.25%
5 YEAR CAGR
42.38%
10 YEAR CAGR